These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 3590814

  • 21. [Safety and tolerability of beta-blockers in severe cardiac decompensation from dilated cardiomyopathy].
    Sinagra G, Perkan A, Zecchin M, Di Lenarda A, Lardieri G, Rakar S, Secoli G, Pinamonti B, Camerini F.
    G Ital Cardiol; 1995 Oct; 25(10):1255-63. PubMed ID: 8682221
    [Abstract] [Full Text] [Related]

  • 22. Haemodynamic effects of nitroglycerin infusion in patients with postinfarction heart failure.
    Korewicki J, Kraska T, Ostrzycki A, Opolski G.
    Cor Vasa; 1985 Oct; 27(4):251-8. PubMed ID: 3931975
    [Abstract] [Full Text] [Related]

  • 23. [Acute hemodynamic effects of alifedrine in patients with heart failure].
    Schanzenbächer P, Riegger G, Liebau G, Hockerts T, Kochsiek K.
    Z Kardiol; 1984 Feb; 73(2):95-100. PubMed ID: 6719988
    [Abstract] [Full Text] [Related]

  • 24. [Hemodynamics and clinical data in chronic coronary disease with severe left ventricular systolic dysfunction].
    Marinato PG, Dametto E, Maragno I, Razzolini R, Chinellato P, Santostasi G, Dalla Volta S.
    Cardiologia; 1996 Apr; 41(4):349-59. PubMed ID: 8674104
    [Abstract] [Full Text] [Related]

  • 25. [Effects of acute and chronic vasodilator administration on hemodynamics and catecholamine concentration in chronic left heart failure (author's transl)].
    Klein W, Goebel R.
    Z Kardiol; 1980 Feb; 69(2):120-5. PubMed ID: 6779433
    [No Abstract] [Full Text] [Related]

  • 26. [Neurohumoral and hemodynamic effects in combination therapy of enoximone and dopamine].
    Mitrovic V, Neuzner J, Opper H, Thormann J, Schlepper M.
    Z Kardiol; 1994 Feb; 83 Suppl 2():37-48. PubMed ID: 8091823
    [Abstract] [Full Text] [Related]

  • 27. Sustained haemodynamic effects of enalapril in left ventricular failure.
    Kjekshus JK, Søyland E, Dickstein K, Abrahamsen AM, Gundersen T.
    J Hypertens Suppl; 1983 Oct; 1(1):143-5. PubMed ID: 6100603
    [Abstract] [Full Text] [Related]

  • 28. Acute and chronic haemodynamic effects of prazosin in left ventricular failure.
    Stein L, Foster PR, Friedman AW, Statza J, McHenry PL.
    Br Heart J; 1981 Feb; 45(2):186-92. PubMed ID: 7459177
    [Abstract] [Full Text] [Related]

  • 29. Haemodynamic effect of prazosin during hyperosmolar mannitol load in essential hypertension.
    Pechán J, Veres I, Ondrejka P.
    Cor Vasa; 1989 Feb; 31(6):467-75. PubMed ID: 2517718
    [Abstract] [Full Text] [Related]

  • 30. Paradox of improved exercise but not resting hemodynamics with short-term prazosin in chronic heart failure.
    Rubin SA, Chatterjee K, Gelberg HJ, Ports TA, Brundage BH, Parmley WW.
    Am J Cardiol; 1979 Apr; 43(4):810-5. PubMed ID: 425918
    [Abstract] [Full Text] [Related]

  • 31. Acute and chronic cardiocirculatory effects of oral prazosin in chronic refractory heart failure.
    Hayashi H, Sassa H, Oba M, Fukaya T, Okubo M, Niwa T, Matsui E.
    Jpn Heart J; 1980 Nov; 21(6):827-36. PubMed ID: 7007686
    [Abstract] [Full Text] [Related]

  • 32. The acute and chronic haemodynamic effects of prazosin in severe congestive cardiac failure.
    Harper RW, Claxton H, Middlebrook K, Anderson S, Pitt A.
    Med J Aust; 1980 Jul 26; 2(SP1):36-8. PubMed ID: 7421721
    [No Abstract] [Full Text] [Related]

  • 33. Haemodynamic effects of prazosin in CHF.
    Reuben SR, Kuan P, Gale EV, Wilde PM.
    Acta Med Scand Suppl; 1981 Jul 26; 652():145-8. PubMed ID: 6949460
    [Abstract] [Full Text] [Related]

  • 34. Sustained effectiveness of chronic prazosin therapy in severe chronic congestive heart failure.
    Bertel O, Burkart F, Bühler FR.
    Am Heart J; 1981 May 26; 101(5):529-33. PubMed ID: 7223592
    [Abstract] [Full Text] [Related]

  • 35. Attenuation of prazosin effect on cardiac output in chronic heart failure.
    Arnold SB, Williams RL, Ports TA, Baughman RA, Benet LZ, Parmley WW, Chatterjee K.
    Ann Intern Med; 1979 Sep 26; 91(3):345-9. PubMed ID: 475164
    [Abstract] [Full Text] [Related]

  • 36. Dynamic responses to continuous use of prazosin and hydralazine in patients with refractory heart failure.
    Elkayam U, Mathur M, Frishman W, LeJemtel T, Strom J, Sonnenblick EH.
    Clin Pharmacol Ther; 1981 Jul 26; 30(1):23-30. PubMed ID: 7237894
    [Abstract] [Full Text] [Related]

  • 37. Therapeutic application of prazosin in chronic refractory congestive heart failure. Tolerance and "tachyphylaxis" in perspective.
    Awan NA, Needham KE, Evenson MK, Amsterdam EE, Mason DT.
    Am J Med; 1981 Jul 26; 71(1):153-60. PubMed ID: 7246573
    [Abstract] [Full Text] [Related]

  • 38. Acute haemodynamic effects of oral prazosin in severe mitral regurgitation.
    Mehta J, Feldman RL, Nichols WW, Pepine CJ, Conti CR.
    Br Heart J; 1980 May 26; 43(5):556-60. PubMed ID: 7378216
    [Abstract] [Full Text] [Related]

  • 39. Acute hemodynamic and long-term clinical effects of prazosin in the treatment of chronic congestive heart failure.
    von der Lippe G, Ohm OJ, Lund-Johansen P.
    Acta Med Scand; 1981 May 26; 210(3):213-6. PubMed ID: 7293839
    [Abstract] [Full Text] [Related]

  • 40. Non-invasive radiocardiographic assessment of the effects of prazosin in congestive heart failure.
    Nakajima H, Yui Y, Kawashita K, Yoshida A, Kawai C.
    Jpn Circ J; 1982 May 26; 46(5):468-72. PubMed ID: 7077811
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.